Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells

Experimental Eye Research

Volumn 94, Issue 1, 2012, Pages 157-173

  Mergler, Stefan ^a   Cheng, Yating ^a   Skosyrski, Sergej ^a   Garreis, Fabian ^b   Pietrzak, Piotr ^a,c   Kociok, Norbert ^a   Dwarakanath, Abhilash ^d   Reinach, Peter S ^e   Kakkassery, Vinodh ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d UNIVERSITY OF MUNICH   (Germany)

^e STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Calcium; Cannabinoid receptor; Etoposide; Human retinoblastoma; Planar patch clamp technique; Transient receptor potential channels

Indexed keywords

CALCIUM; CANNABINOID RECEPTOR; CAPSAICIN; ETOPOSIDE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; PATCH CLAMP; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RETINOBLASTOMA;

CALCIUM; CAPSAICIN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; PATCH-CLAMP TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB1; RETINAL NEOPLASMS; RETINOBLASTOMA; RNA, MESSENGER; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84855854181     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.12.002     Document Type: Article

References (92)

1. Akiba Y., Kato S., Katsube K., Nakamura M., Takeuchi K., Ishii H., Hibi T. Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats. Biochem. Biophys. Res. Commun. 2004, 321:219-225.
2. Atoyan R., Shander D., Botchkareva N.V. Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J.Invest. Dermatol. 2009, 129:2312-2315.
3. Bach G. Mucolipin 1: endocytosis and cation channel-a review. Pflugers Arch. 2005, 451:313-317.
4. Bai V.U., Murthy S., Chinnakannu K., Muhletaler F., Tejwani S., Barrack E.R., Kim S.H., Menon M., Veer Reddy G.P. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids. Int. J. Oncol. 2010, 36:443-450.
5. Barnes S., Haynes L.W. Low-voltage-activated calcium channels in human retinoblastoma cells. Brain Res. 1992, 598:19-22.
6. Beck B., Bidaux G., Bavencoffe A., Lemonnier L., Thebault S., Shuba Y., Barrit G., Skryma R., Prevarskaya N. Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators. Cell Calcium 2007, 41:285-294.
7. Bertolesi G.E., Shi C., Elbaum L., Jollimore C., Rozenberg G., Barnes S., Kelly M.E. The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol. Pharmacol. 2002, 62:210-219.
8. Bertolesi G.E., Walia Da S.R., Jollimore C.A., Shi C., Barnes S., Kelly M.E. Ca(v)3.1 splice variant expression during neuronal differentiation of Y-79 retinoblastoma cells. Neuroscience 2006, 141:259-268.
9. Bidaux G., Roudbaraki M., Merle C., Crθpin A., Delcourt P., Slomianny C., Thebault S., Bonnal J.L., Benahmed M., Cabon F., Mauroy B., Prevarskaya N. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocr. Relat. Cancer 2005, 12:367-382.
10. Bodding M. TRP proteins and cancer. Cell. Signal. 2007, 19:617-624.
11. Bruggemann A., Stoelzle S., George M., Behrends J.C., Fertig N. Microchip technology for automated and parallel patch-clamp recording. Small 2006, 2:840-846.
12. Bruggemann A., Farre C., Haarmann C., Haythornthwaite A., Kreir M., Stoelzle S., George M., Fertig N. Planar patch clamp: advances in electrophysiology. Methods Mol. Biol. 2008, 491:165-176.
13. Burkhart D.L., Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer 2008, 8:671-682.
14. Capolongo L., Amboldi N., Ballinari D., Cozzi P., Melegaro G., Ripamonti M., Vaghi F., Grandi M. Reversal of multidrug resistance by new dihydropyridines with low calcium antagonist activity. Acta Oncol. 1994, 33:787-791.
15. Caprodossi S., Amantini C., Nabissi M., Morelli M.B., Farfariello V., Santoni M., Gismondi A., Santoni G. Capsaicin (CPS) promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis 2011.
16. Casas S., Novials A., Reimann F., Gomis R., Gribble F.M. Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4. Diabetologia 2008, 51:2252-2262.
17. Christensen A.P., Corey D.P. TRP channels in mechanosensation: direct or indirect activation?. Nat. Rev. Neurosci. 2007, 8:510-521.
18. Cordeiro S., Seyler S., Stindl J., Milenkovic V.M., Strauss O. Heat-sensitive TRPV channels in retinal pigment epithelial cells: regulation of VEGF-A secretion. Invest. Ophthalmol. Vis. Sci. 2010, 51:6001-6008.
19. Crawford D.C., Moulder K.L., Gereau R.W., Story G.M., Mennerick S. Comparative effects of heterologous TRPV1 and TRPM8 expression in rat hippocampal neurons. PLoS. ONE 2009, 4. 8166.
20. Czifra G., Varga A., Nyeste K., Marincsak R., Toth B.I., Kovacs I., Kovacs L., Biro T. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J.Cancer Res. Clin. Oncol. 2009, 135:507-514.
21. De Petrocellis L., Ligresti A., Moriello A.S., Allara M., Bisogno T., Petrosino S., Stott C.G., Di M.V. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Ophthalmol. 2010.
22. Everaerts W., Nilius B., Owsianik G. The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog. Biophys. Mol. Biol. 2010, 103:2-17.
23. Everaerts W., Zhen X., Ghosh D., Vriens J., Gevaert T., Gilbert J.P., Hayward N.J., McNamara C.R., Xue F., Moran M.M., Strassmaier T., Uykal E., Owsianik G., Vennekens R., De R.D., Nilius B., Fanger C.M., Voets T. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc. Natl. Acad. Sci. U S A 2010, 107:19084-19089.
24. Fertig N., Blick R.H., Behrends J.C. Whole cell patch clamp recording performed on a planar glass chip. Biophys. J. 2002, 82:3056-3062.
25. Gevaert T., Vriens J., Segal A., Everaerts W., Roskams T., Talavera K., Owsianik G., Liedtke W., Daelemans D., Dewachter I., Van L.F., Voets T., De R.D., Nilius B. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J.Clin. Invest. 2007, 117:3453-3462.
26. Gkika D., Prevarskaya N. Molecular mechanisms of TRP regulation in tumor growth and metastasis. Biochim. Biophys. Acta 2009, 1793:953-958.
27. Grabowski D.R., Dubyak G.R., Rybicki L., Hidaka H., Ganapathi R. Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes. Biochem. Pharmacol. 1998, 56:345-349.
28. Grynkiewicz G., Poenie M., Tsien R.Y. Anew generation of Ca2+ indicators with greatly improved fluorescence properties. J.Biol. Chem. 1985, 260:3440-3450.
29. Guilbert A., Dhennin-Duthille I., Hiani Y.E., Haren N., Khorsi H., Sevestre H., Ahidouch A., Ouadid-Ahidouch H. Expression of TRPC6 channels in human epithelial breast cancer cells. BMC. Cancer 2008, 8:125.
30. Hanano T., Hara Y., Shi J., Morita H., Umebayashi C., Mori E., Sumimoto H., Ito Y., Mori Y., Inoue R. Involvement of TRPM7 in cell growth as a spontaneously activated Ca2+ entry pathway in human retinoblastoma cells. J.Pharm. Sci. 2004, 95:403-419.
31. Hartel M., di Mola F.F., Selvaggi F., Mascetta G., Wente M.N., Felix K., Giese N.A., Hinz U., Di S.P., Buchler M.W., Friess H. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut 2006, 55:519-528.
32. Hirooka K., Bertolesi G.E., Kelly M.E., Denovan-Wright E.M., Sun X., Hamid J., Zamponi G.W., Juhasz A.E., Haynes L.W., Barnes S. T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiation. J.Neurophysiol. 2002, 88:196-205.
33. Jeske N.A., Patwardhan A.M., Gamper N., Price T.J., Akopian A.N., Hargreaves K.M. Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J.Biol. Chem. 2006, 281:32879-32890.
34. Kobayashi K., Fukuoka T., Obata K., Yamanaka H., Dai Y., Tokunaga A., Noguchi K. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J.Comp. Neurol. 2005, 493:596-606.
35. Kochukov M.Y., McNearney T.A., Fu Y., Westlund K.N. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. Am. J. Physiol. Cell. Physiol. 2006, 291:C424-C432.
36. Kochukov M.Y., McNearney T.A., Yin H., Zhang L., Ma F., Ponomareva L., Abshire S., Westlund K.N. Tumor necrosis factor-alpha (TNF-alpha) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes. Mol. Pain 2009, 5:49.
37. Lehen'kyi V., Prevarskaya N. Oncogenic TRP channels. Adv. Exp. Med. Biol. 2011, 704:929-945.
38. Leonelli M., Martins D.O., Britto L.R. TRPV1 receptors are involved in protein nitration and Muller cell reaction in the acutely axotomized rat retina. Exp. Eye Res. 2010, 91:755-768.
39. Li C., Jones P.M., Persaud S.J. Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells. Cell. Physiol. Biochem 2010, 26:187-196.
40. Lohmann D. Retinoblastoma. Adv. Exp. Med. Biol. 2010, 685:220-227.
41. Maenpaa H., Gegelashvili G., Tahti H. Expression of glutamate transporter subtypes in cultured retinal pigment epithelial and retinoblastoma cells. Curr. Eye Res. 2004, 28:159-165.
42. Mahmud A., Santha P., Paule C.C., Nagy I. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. Neuroscience 2009, 162:1202-1211.
43. Mastrangelo D., De F.S., Di L.A., Lentini L., Hadjistilianou T. The retinoblastoma paradigm revisited. Med. Sci. Monit. 2008, 14:RA231-RA240.
44. McFall R.C., Sery T.W., Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977, 37:1003-1010.
45. McKemy D.D., Neuhausser W.M., Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002, 416:52-58.
46. Mergler S. Ca2+ channel characteristics in neuroendocrine tumor cell cultures analyzed by color contour plots. J.Neurosci. Methods 2003, 129:169-181.
47. Mergler S., Strowski M.Z., Kaiser S., Plath T., Giesecke Y., Neumann M., Hosokawa H., Kobayashi S., Langrehr J., Neuhaus P., Plockinger U., Wiedenmann B., Grotzinger C. Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells. Neuroendocrinology 2007, 85:81-92.
48. Mergler S., Valtink M., Coulson-Thomas V.J., Lindemann D., Reinach P.S., Engelmann K., Pleyer U. TRPV channels mediate temperature-sensing in human corneal endothelial cells. Exp. Eye Res. 2010, 90:758-770.
49. Mergler S., Garreis F., Sahlmuller M., Reinach P.S., Paulsen F., Pleyer U. Thermosensitive transient receptor potential channels in human corneal epithelial cells. J.Cell. Physiol. 2011, 226:1828-1842.
50. Mergler S., Skrzypski M., Sassek M., Pietrzak P., Pucci C., Wiedenmann B., Strowski M.Z. Thermo-sensitive transient receptor potential vanilloid channel-1regulates intracellular calcium and triggers chromogranin A secretion in pancreatic neuroendocrine BON-1 tumor cells. Cell Signal 2012, 24:233-246.
51. Milligan C.J., Li J., Sukumar P., Majeed Y., Dallas M.L., English A., Emery P., Porter K.E., Smith A.M., McFadzean I., Beccano-Kelly D., Bahnasi Y., Cheong A., Naylor J., Zeng F., Liu X., Gamper N., Jiang L.H., Pearson H.A., Peers C., Robertson B., Beech D.J. Robotic multiwell planar patch-clamp for native and primary mammalian cells. Nat. Protoc. 2009, 4:244-255.
52. Miyake N., Fujita R., Ishikawa M., Takayanagi M., Takayanagi Y., Sasaki K. Reversal of multidrug resistance in human leukemia K562 by tamolarizine, a novel calcium antagonist. Jpn. J. Pharmacol. 2000, 82:265-268.
53. Morrison T.B., Weis J.J., Wittwer C.T. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998, 24. 954-958, 960, 962.
54. Mukhopadhyay S., Shim J.Y., Assi A.A., Norford D., Howlett A.C. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. Chem. Phys. Lipids 2002, 121:91-109.
55. Nilius B., Owsianik G. Channelopathies converge on TRPV4. Nat. Genet. 2010, 42:98-100.
56. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007, 87:165-217.
57. Okada Y., Reinach P.S., Shirai K., Kitano A., Winston W., Kao Y., Flanders K.C., Miyajima M., Liu H., Zhang J., Saika S. TRPV1 involvement in the inflammatory tissue fibrosis in mice. Am. J. Pathol. 2011, (Epub ahead of print).
58. Pajak B., Orzechowski A. Clusterin: the missing link in the calcium-dependent resistance of cancer cells to apoptogenic stimuli. Postepy. Hig. Med. Dosw. (Online) 2006, 60:45-51.
59. Pamir E., George M., Fertig N., Benoit M. Planar patch-clamp force microscopy on living cells. Ultramicroscopy 2008, 108:552-557.
60. Pan Z., Wang Z., Yang H., Zhang F., Reinach P.S. TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2011, 52:485-493.
61. Patwardhan A.M., Jeske N.A., Price T.J., Gamper N., Akopian A.N., Hargreaves K.M. The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc. Natl. Acad. Sci. U S A 2006, 103:11393-11398.
62. Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obes. (Lond) 2006, 30(Suppl 1):S13-S18.
63. del Pilar G.M., Waloga G., Nasi E. Electrical properties of Y-79 cells, a multipotent line of human retinoblastoma. J.Neurophysiol. 1993, 70:1476-1486.
64. del Pilar G.M., Waloga G., Nasi E. Induction of voltage-dependent sodium channels by invitro differentiation of human retinoblastoma cells. J.Neurophysiol. 1993, 70:1487-1496.
65. Pingle S.C., Matta J.A., Ahern G.P. Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb. Exp. Pharmacol. 2007, 155-171.
66. Prevarskaya N., Flourakis M., Bidaux G., Thebault S., Skryma R. Differential role of TRP channels in prostate cancer. Biochem. Soc. Trans. 2007, 35:133-135.
67. Prevarskaya N., Zhang L., Barritt G. TRP channels in cancer. Biochim. Biophys. Acta 2007, 1772:937-946.
68. Ramakers C., Ruijter J.M., Deprez R.H., Moorman A.F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003, 339:62-66.
69. Ramsey I.S., Delling M., Clapham D.E. An introduction to TRP channels. Annu. Rev. Physiol. 2006, 68:619-647.
70. Sabado A.C. Molecular biology of retinoblastoma. Clin. Transl. Oncol. 2008, 10:389-394.
71. Sanchez M.G., Sanchez A.M., Collado B., Malagarie-Cazenave S., Olea N., Carmena M.J., Prieto J.C., Diaz-Laviada I.I. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur. J. Neurosci. 2005, 515:20-27.
72. Sappington R.M., Sidorova T., Long D.J., Calkins D. TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Invest. Ophthalmol. Vis. Sci. 2009, 50:717-728.
73. Shen Y., Heimel J.A., Kamermans M., Peachey N.S., Gregg R.G., Nawy S. Atransient receptor potential-like channel mediates synaptic transmission in rod bipolar cells. J.Neurosci. 2009, 29:6088-6093.
74. Smith G.D., Gunthorpe M.J., Kelsell R.E., Hayes P.D., Reilly P., Facer P., Wright J.E., Jerman J.C., Walhin J.P., Ooi L., Egerton J., Charles K.J., Smart D., Randall A.D., Anand P., Davis J.B. TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature 2002, 418:186-190.
75. Staruschenko A., Jeske N.A., Akopian A.N. Contribution of TRPV1-TRPA1 interaction to the single channel properties of the TRPA1 channel. J.Biol. Chem. 2010, 285:15167-15177.
76. Stephan H., Boeloeni R., Eggert A., Bornfeld N., Schueler A. Photodynamic therapy in retinoblastoma: effects of verteporfin on retinoblastoma cell lines. Invest. Ophthalmol. Vis. Sci. 2008, 49:3158-3163.
77. Thakur G.A., Tichkule R., Bajaj S., Makriyannis A. Latest advances in cannabinoid receptor agonists. Expert. Opin. Ther. Pat. 2009, 19:1647-1673.
78. Tominaga M., Caterina M.J. Thermosensation and pain. J.Neurobiol. 2004, 61:3-12.
79. Tominaga M., Tominaga T. Structure and function of TRPV1. Pflugers Arch. 2005, 451:143-150.
80. Tsavaler L., Shapero M.H., Morkowski S., Laus R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res. 2001, 61:3760-3769.
81. Vanden Abeele F., Shuba Y., Roudbaraki M., Lemonnier L., Vanoverberghe K., Mariot P., Skryma R., Prevarskaya N. Store-operated Ca2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis. Cell Calcium 2003, 33:357-373.
82. Vandesompele J., De P.K., Pattyn F., Poppe B., Van R.N., De P.A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. RESEARCH0034.
83. Venkatachalam K., Montell C. TRP channels. Annu. Rev. Biochem. 2007, 76:387-417.
84. Venkatachalam K., Zheng F., Gill D.L. Control of TRPC and store-operated channels by protein kinase C. Novartis. Found. Symp. 2004, 258:172-185.
85. Voets T., Droogmans G., Wissenbach U., Janssens A., Flockerzi V., Nilius B. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 2004, 430:748-754.
86. Vriens J., Appendino G., Nilius B. Pharmacology of vanilloid transient receptor potential cation channels. Mol. Pharmacol. 2009, 75:1262-1279.
87. Yamada T., Ueda T., Ugawa S., Ishida Y., Imayasu M., Koyama S., Shimada S. Functional expression of transient receptor potential vanilloid 3 (TRPV3) in corneal epithelial cells: involvement in thermosensation and wound healing. Exp. Eye Res. 2009.
88. Yang H., Wang Z., Capo-Aponte J.E., Zhang F., Pan Z., Reinach P.S. Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells. Exp. Eye Res. 2010.
89. Zhang L., Barritt G.J. Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Res. 2004, 64:8365-8373.
90. Zhang L., Barritt G.J. TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?. Endocr. Relat. Cancer 2006, 13:27-38.
91. Zhang F., Yang H., Wang Z., Mergler S., Liu H., Kawakita T., Tachado S.D., Pan Z., Capo-Aponte J.E., Pleyer U., Koziel H., Kao W.W., Reinach P.S. Transient receptor potential vanilloid 1 activation induces inflammatory cytokine release in corneal epithelium through MAPK signaling. J.Cell. Physiol. 2007, 213:730-739.
92. Zimov S., Yazulla S. Vanilloid receptor 1 (TRPV1/VR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells. Vis. Neurosci. 2007, 24:581-591.